About Careers Internship MedBlog Contact us

Revolutionary 'Trigger' Paves Way to Halt the Spread of Breast Cancer Cells

by Dr. Trupti Shirole on June 11, 2015 at 5:24 AM
Font : A-A+

Revolutionary 'Trigger' Paves Way to Halt the Spread of Breast Cancer Cells

The majority of deaths from breast cancer are caused because of the tumor spreading to other parts of the body. The lung is often the first organs to be affected. In a revolutionary breakthrough, scientists at University of Edinburgh have discovered the triggering factor for the spread of breast cancer cells. This discovery will help the scientists to find new therapies to halt the spread of breast cancer tumor.

The research team investigated the role that immune cells called macrophages play in helping cells from the original tumor to spread, and found that macrophages require signalling molecules called chemokines to communicate with breast cancer cells. When the researchers blocked these signals in mice, they found that the number of secondary tumors in the lungs was reduced by up to two thirds. The results suggest that targeting a chemokine receptor signalling molecule called CCR1 may result in fewer unwanted side effects for patients while stopping the spread of breast cancer cells.


Professor Jeffrey Pollard said, "The findings open the door to the development of treatments that target the tumor micro-environment, which may stop the deadly progression of breast cancer in its tracks."

The study is published in the Journal of Experimental Medicine.

Source: ANI


Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Revolutionary 'Trigger' Paves Way to Halt the Spread of Breast Cancer Cells Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests